PMEL and neoplasm: In contrast, the tumor of the current patient demonstrated a complex immunophenotype: SMA positivity with partial melan‐A expression, absence of HMB‐45 and PNL2, and negativity for AE1/AE3, S‐100, and hepatocyte.